Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone

Huiling Han, MD, Keith Westerman, BS, Vaughn Ostland, PhD, Patrick Gutschow, MS, Gordana Olbina, PhD, Jacqueline da Silva Guimarães, PhD, Juçara Gastaldi Cominal, M.Sc, Ana Maria de Souza, PhD, Ana Cristina Silva Pinto, MD, Stefano Rivella, PhD, Yelena Ginzburg, MD, Mark D. Fleming, MD DPhil, Mark Westerman, PhD

Blood (2016) 128 (22): 1272.

https://doi.org/10.1182/blood.V128.22.1272.1272

Published: 2016

Journal Articles

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Ioannis Papassotiriou, PhD, Katerina Larrisi, MD, Alexandra Margeli, PhD, Dimitrios Christoulas, Maria Dimopoulou, MD, Vaughn Ostland, PhD, Christos Poziopoulos, Mark Westerman, PhD, Marianna Politou, MD, Ersi Voskaridou, MD, Evangelos Terpos, MD PhD

Blood (2016) 128 (22): 3646.

https://doi.org/10.1182/blood.V128.22.3646.3646

Published: 2016

Journal Articles

Validation of the Intrinsic Hepcidin IDx TM Test, an LDT for Clinical Hepcidin Assessment

Patrick Gutschow, MS, Keith Westerman, BS, Huiling Han, MD, Vaughn Ostland, PhD, Gordana Olbina, PhD, William Paxton, MD PhD, Mark Westerman, PhD

Blood (2016) 128 (22): 2456.

https://doi.org/10.1182/blood.V128.22.2456.2456

Published: 2016

Journal Articles

Increased Hepcidin Expression in β-Thalassemic Mice Treated with Apo-Transferrin Is Associated with Increased Smad1/5/8 and Decreased Erk1/2 Pathway Activation

Huiyong Chen, PhD, Tenzin Choesang, Petra Pham, Weili Bao, Maria Feola, Huihui Li, MS, Mark Westerman, PhD, Guiyuan Li, Antonia Follenzi, Lionel Blanc, PhD, Stefano Rivella, PhD, Robert E Fleming, MD, Yelena Ginzburg, MD

Blood (2014) 124 (21): 747.

https://doi.org/10.1182/blood.V124.21.747.747

Published: 2014

Journal Articles

Evidence Of Relative Iron Deficiency in Apheresis Platelet Donors Correlates With Donation Frequency

Frances Condon, Huihui Li, MS, Debra Kessler, RN, Vijay Nandi, Tomas Ganz, MD, PhD, Elizabeta Nemeth, PhD, Mark Westerman, PhD, Beth H Shaz, MD, Yelena Ginzburg, MD

Blood (2013) 122 (21): 1155.

https://doi.org/10.1182/blood.V122.21.1155.1155

Published: 2013

Journal Articles

Hepcidin Production in Ineffective Erythropoiesis and Chronic Hemolysis: Insights on the Crosstalk Between Erythropoiesis and Iron Metabolism

Kleber Yotsumoto Fertrin, MD, Carolina Lanaro, B.Sc., Ph, D, Carla Fernanda Franco-Penteado, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Mariana Rezende Bandeira Mello, BSc, MSc, PhD, Marcos André Cavalcanti Bezerra, MSc, PhD, Betania Lucena Borges Tavares Domingues, BSc, Gordana Olbina, PhD, Sara T. Olalla Saad, MD, PhD, Aderson S Araujo, MD, PhD, Mark Westerman, PhD, Fernando Ferreira Costa, MD, PhD

Blood (2011) 118 (21): 346.

https://doi.org/10.1182/blood.V118.21.346.346

Published: 2011

Journal Articles

Hepcidin in Male Double Red Blood Cell Donors - Relationship Between Parameters of Iron Metabolism and Erythropoiesis

Shuo Wang, Huihui Li, MS, Lisa Sarran, Gordana Olbina, PhD, Mark Westerman, PhD, Elizabeta Nemeth, PhD, Eric E. Bouhassira, PhD, Tomas Ganz, MD, PhD, Yelena Ginzburg, MD

Blood (2011) 118 (21): 2109.

https://doi.org/10.1182/blood.V118.21.2109.2109

Published: 2011

Journal Articles

Is Serum Hepcidin a Useful Diagnostic Test for Iron Deficiency?

Sant-Rayn S Pasricha, MBBS, MPH, Zoe McQuilten, MBBS, FRACP, FRCPA, Mark Westerman, PhD, Anthony Keller, MBBS, FRACP, Elizabeta Nemeth, PhD, Tomas Ganz, MD, PhD, Erica M. Wood, MBBS, FRACP, FRCPA

Blood (2010) 116 (21): 2056.

https://doi.org/10.1182/blood.V116.21.2056.2056

Published: 2010

Journal Articles

Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loading.

Ann-Kathrin Eisfeld, Mark Westerman, PhD, Rainer Krahl, Sabine Leiblein, PhD, Uwe Gerd Liebert, Marianne Hehme, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD

Blood (2009) 114 (22): 4047.

https://doi.org/10.1182/blood.V114.22.4047.4047

Published: 2009

Journal Articles

The Clinical and Genetic Spectrum of TMPRSS6 Mutations Leading to Inappropriate Hepcidin Expression and Iron Refractory Iron Deficiency Anemia (IRIDA).

Matthew M Heeney, MD, Dean R. Campagna, Mark Westerman, PhD, Mark D. Fleming, MD, DPhil

Blood (2009) 114 (22): 629.

https://doi.org/10.1182/blood.V114.22.629.629

Published: 2009

Journal Articles

Relationship Between Epoetin Alfa (EPO) Treatment and Serum Hepcidin Levels in Anemic Patients with Rheumatoid Arthritis (RA)

Victor Moyo, MD, Robert Kersting, PharmD, Mark Westerman, PhD, Wayne Langholff, PhD, Ruchi Rastogi, PharmD, Suneel Mundle, PhD

Blood (2008) 112 (11): 3450.

https://doi.org/10.1182/blood.V112.11.3450.3450

Published: 2008

Journal Articles

Immunoassay for Human Hepcidin in Blood

Gordana Olbina, PhD, Ximena Pastorino, Domenico Girelli, MD, PhD, Kimberly O. O’Brien, PhD, Elizabeta Nemeth, PhD, Tomas Ganz, MD, PhD, Mark Westerman, PhD

Blood (2008) 112 (11): 3839.

https://doi.org/10.1182/blood.V112.11.3839.3839

Published: 2008

NARROW

A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Validation of the Intrinsic Hepcidin IDx TM Test, an LDT for Clinical Hepcidin Assessment

Increased Hepcidin Expression in β-Thalassemic Mice Treated with Apo-Transferrin Is Associated with Increased Smad1/5/8 and Decreased Erk1/2 Pathway Activation

Evidence Of Relative Iron Deficiency in Apheresis Platelet Donors Correlates With Donation Frequency

Hepcidin Production in Ineffective Erythropoiesis and Chronic Hemolysis: Insights on the Crosstalk Between Erythropoiesis and Iron Metabolism

Hepcidin in Male Double Red Blood Cell Donors - Relationship Between Parameters of Iron Metabolism and Erythropoiesis

Is Serum Hepcidin a Useful Diagnostic Test for Iron Deficiency?

Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loading.

The Clinical and Genetic Spectrum of TMPRSS6 Mutations Leading to Inappropriate Hepcidin Expression and Iron Refractory Iron Deficiency Anemia (IRIDA).

Relationship Between Epoetin Alfa (EPO) Treatment and Serum Hepcidin Levels in Anemic Patients with Rheumatoid Arthritis (RA)

Immunoassay for Human Hepcidin in Blood

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only